- Recent Funding
- Investors
- 5AM Ventures
5AM Ventures portfolio
5AM Ventures has 2 portfolio companies on record at Recent Funding. It led 2 of the 2 rounds it joined. Its most recent investment on record is GlycoEra's $49M Series A round in November 2021, which it led, alongside Sofinnova Partners, Roche Venture Fund and LimmaTech Biologics. By category, its portfolio leans toward Health and bio (2). It has co-invested with Sofinnova Partners, Roche Venture Fund and LimmaTech Biologics.
What 5AM Ventures invests in
- Health and bio · 2 · 100%
How 5AM Ventures invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 2 100% | $89M |
Share is of the 2 rounds on Recent Funding that name 5AM Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
5AM Ventures portfolio companies
GGlycoEra$49MSeries A · Nov 2021
KKinaset Therapeutics$40MSeries A · Nov 2020
| Company | Round with 5AM Ventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $49M · lead | $179M | May 27, 2025 Series B+ |
Health and bio |
Series A · $40M · lead | $143M | Jan 9, 2026 Series B+ |
Most frequent co-investors
SSofinnova Partners1 shared round · last Nov 5, 2021
RRoche Venture Fund1 shared round · last Nov 5, 2021
- LLimmaTech Biologics1 shared round · last Nov 5, 2021
AAtlas Venture1 shared round · last Nov 30, 2020
GGimv1 shared round · last Nov 30, 2020
Similar investors
CCalm/Storm VC2 companies · 2 deals in 12 mo
GGoHub Ventures2 companies · 2 deals in 12 mo
HHuatai Zijin Investment2 companies · 2 deals in 12 mo
IIIMA Ventures2 companies · 2 deals in 12 mo
SSeventure Partners2 companies · 2 deals in 12 mo
SSound Bioventures2 companies · 2 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists 5AM Ventures, which is a subset of its real portfolio. API: /api/v1/investors/5am-ventures (get a free API key). More: the most active VC firms and new venture capital funds.